{
    "organizations": [],
    "uuid": "5472eff11467bf51d3d7c2d2004e80dccf0f8dc1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-armo-biosciences-sees-ipo-of-up-to/brief-armo-biosciences-sees-ipo-of-up-to-6-7-mln-shares-of-common-stock-estimated-ipo-price-between-14-and-16-shr-idUSFWN1PB0SP",
    "ord_in_thread": 0,
    "title": "BRIEF-ARMO Biosciences Sees IPO Of Up To 6.7 Mln Shares Of Common Stock, Estimated IPO Price Between $14 And $16/Shr",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 16 (Reuters) -\n* ARMO BIOSCIENCES INC SEES IPO OF UP TO 6.7 MILLION SHARES OF COMMON STOCK AND ESTIMATED IPO PRICE BETWEEN $14.00 AND $16.00 PER SHARE - SEC FILING\n* ARMO BIOSCIENCES - INTENDS TO USE ABOUT $35 MILLION OF IPO PROCEEDS TO FUND DEVELOPMENT OF AM0010 FOR TREATMENT OF PDAC, INCLUDING PHASE 3 CLINICAL TRIAL\n* ARMO BIOSCIENCES - INTENDS TO USE ABOUT $35 MILLION OF IPO PROCEEDS TO FUND TWO PLANNED PHASE 2B CLINICAL TRIALS IN NSCLC Source text: ( bit.ly/2FGsF7g )\n ",
    "published": "2018-01-16T21:15:00.000+02:00",
    "crawled": "2018-01-17T19:44:51.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "armo",
        "bioscience",
        "inc",
        "see",
        "ipo",
        "million",
        "share",
        "common",
        "stock",
        "estimated",
        "ipo",
        "price",
        "per",
        "share",
        "sec",
        "filing",
        "armo",
        "bioscience",
        "intends",
        "use",
        "million",
        "ipo",
        "proceeds",
        "fund",
        "development",
        "am0010",
        "treatment",
        "pdac",
        "including",
        "phase",
        "clinical",
        "trial",
        "armo",
        "bioscience",
        "intends",
        "use",
        "million",
        "ipo",
        "proceeds",
        "fund",
        "two",
        "planned",
        "phase",
        "2b",
        "clinical",
        "trial",
        "nsclc",
        "source",
        "text"
    ]
}